Pharmaron (Exton) Lab Services LLC
Exton, PA Doing business as Absorption Systems
- UEI
- G7FBJ3M3JFF3
- CAGE
- 4TR39
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Other
- Corporate family
-
-
- Carlsbad, CA MMXQBTUNPEH3
-
- SAM.gov registration date
- Physical address
- 436 Creamery Way #600, Exton, PA 19341, USA
- Website
- pharmaron.com
- Employees
- 1K-5K
- Estimated annual revenue
- $250M-$500M
- Industry
-
- Industrials
- Capital Goods
- Industrial Conglomerates
- Industrials & Manufacturing
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $44,354 |
| FY2024 | $38,205 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Transporter knockdowns for in vitro drug interaction monitoring | Food and Drug Administration | $818,323 | |
| Transporter knockdowns for in vitro drug interaction monitoring | Food and Drug Administration | $214,696 |
Similar vendors
About the company
Pharmaron (Exton) Lab Services LLC, doing business as Absorption Systems, is a global contract research organization (CRO) specializing in pharmaceutical research and development services. Registered in SAM.gov since 2007, the company is a foreign-owned, for-profit organization classified as a parent entity. As a strategic partner in the pharmaceutical research ecosystem, Pharmaron offers comprehensive testing and analytical services to support drug development, with a particular focus on pharmacokinetic studies, permeability assessments, and advanced scientific research methodologies.
The company has secured multiple federal contract awards from prominent agencies including the National Institute of Neurological Disorders and Stroke (NINDS), Food and Drug Administration (FDA), and National Center for Advancing Translational Sciences. Their contract work encompasses a diverse range of scientific services, such as in-vivo pharmacokinetic (PK) studies for HIV antisense oligonucleotide projects, permeability assessments of Biopharmaceutics Classification System (BCS) drug substances, and specialized testing for COVID-19 related research. Notable contracts include a $1,574,070.36 two-year delivery order for pharmacokinetic and pharmacodynamic studies of ophthalmic intraocular pressure drug formulations, and smaller-scale projects involving compound testing, solubility analysis, and cytochrome P inhibitor research. While most contracts were not set aside for specific business types, one contract with the National Center for Advancing Translational Sciences was designated as a total small business award, demonstrating the company's versatility in federal contracting.
Quick answers
Is Pharmaron (Exton) Lab Services LLC registered in SAM.gov?
Yes. Pharmaron (Exton) Lab Services LLC's SAM.gov registration is active through December 5, 2026.
How much has Pharmaron (Exton) Lab Services LLC received in federal contracts?
Federal contracts obligated $44,354 to Pharmaron (Exton) Lab Services LLC in fiscal year 2025 and $82,558 in fiscal years 2023 through 2027.
What is Pharmaron (Exton) Lab Services LLC's most recent federal award?
Pharmaron (Exton) Lab Services LLC's most recent federal contract award is Quantitation of GM1 in human CSF using method from study 20AXOVP6 (GLP)-rolling sample analysis (75N92E25P00196), from National Human Genome Research Institute (NIH), on July 15, 2025.
On GovTribe
See Pharmaron (Exton) Lab Services LLC's full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors